About & Methodology
How SynMale Evaluates Products
SynMale is an independent educational publication. We do not sell medications, link to pharmacies, or accept affiliate payments.
How We Grade→Editorial Methodology→Corrections Policy→Medical Review Policy→Medical Disclaimer→Editorial Independence→
What we evaluate
Clinical EvidenceIngredient TransparencyRegulatory StatusManufacturing TransparencyPharmacologyReported OnsetDurationReliabilityTolerabilitySafety ProfileMarketing Accuracy
The SynMale Evidence Grade
AA — Strong Clinical Evidence
BB — Good Supporting Evidence
CC — Limited Evidence
DD — Weak / Mostly Marketing Claims
FF — Unsupported or Contradicted Claims
?Unknown — Not Enough Reliable Information
Facts, claims and the space between
Established facts
Consistent findings from regulators and controlled clinical trials.
Published clinical evidence
Peer-reviewed studies, weighed by size and quality.
Independent testing
Regulator or reliable lab analysis of actual product samples.
Manufacturer claims
Statements on labels or official materials—reported, not assumed.
Seller claims
Marketing by retailers or resellers—treated with the most caution.
Unverified information
Anything we could not confirm is labeled as such.
We never present a label claim as fact. Products sharing a stated ingredient are not assumed to be equivalent. Numerical scores are given only where reliable clinical data exists; they are editorial comparison tools, not efficacy guarantees.